Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cubist Pharmaceuticals extends offer to buy Adolor shares until Friday
Yahoo/AP
Wednesday, December 7, 2011 - 11:41am
tags:
Cubist, Adolor, tender offer, M&A
Bullish Call For Zalicus's Z160 Launch
Seeking Alpha
Wednesday, December 7, 2011 - 11:40am
tags:
Zalicus, Z160
Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Study Says
Bloomberg Businessweek
Wednesday, December 7, 2011 - 11:05am
tags:
prostate cancer, AstraZeneca, Watson, Lupron, Abbott Laboratories, Vantas, Trelstar, Zoladex, Endo
PhRMA backs FDA plans for biosimilar fees discussion
In-Pharmatechnologist
Wednesday, December 7, 2011 - 11:03am
tags:
PhRMA, FDA, biosimilars
Lpath Is Many Years Ahead Of The Competition
Seeking Alpha
Wednesday, December 7, 2011 - 11:01am
tags:
Lpath, bioactive lipids
Forest Laboratories: Uncertainty Over Future Winners Increases Risk
Seeking Alpha
Wednesday, December 7, 2011 - 11:00am
tags:
Forest Labs
Aoxing Pharmaceutical Company Announces $3.2 Million Financing
Yahoo
Wednesday, December 7, 2011 - 10:59am
tags:
Aoxing, China
J&J’s Birth-Control Patch Needs More Research on Blood-Clot Risk
Bloomberg
Wednesday, December 7, 2011 - 10:58am
tags:
JNJ, birth control patch, blood clots, Ortho Evra
Ranbaxy Allied With Teva for Lipitor Monetization, Nomura Says
Bloomberg
Wednesday, December 7, 2011 - 10:58am
tags:
Ranbaxy, Teva Pharmaceuticals, Lipitor, generics
Pa. jury awards 3 women $72 million over menopause drug Prempro; punitive damages next
Yahoo/AP
Wednesday, December 7, 2011 - 10:57am
tags:
Prempro, Pfizer, Wyeth, settlements, HRT
Antares Pharmaceuticals: A Buy Based On Exceptional New Product Outlook
Seeking Alpha
Wednesday, December 7, 2011 - 10:52am
tags:
GSK, Pfizer, Teva Pharmaceuticals, Antares
U.S. Weighs Allowing Teva’s Morning-After Pill for All Ages
Bloomberg Businessweek
Tuesday, December 6, 2011 - 7:54pm
tags:
Teva Pharmaceuticals, FDA, morning-after pill, Plan B contraceptive, OTC
Supreme Court hears patent-description fight
Fierce Pharma
Tuesday, December 6, 2011 - 7:51pm
tags:
Supreme Court, patents, Caraco, Novo Nordisk, Prandin, diabetes
Eli Lilly Shares Rise on Alzheimer’s Drug Hopes
Bloomberg
Tuesday, December 6, 2011 - 7:48pm
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Sanofi’s Lantus Doubled Risk of Cancer in Study of Diabetics
Bloomberg
Tuesday, December 6, 2011 - 7:45pm
tags:
diabetes, Lantus, Sanofi, metformin, insulin
Dendreon to sell royalty in Merck hep C drug
Reuters
Tuesday, December 6, 2011 - 4:30pm
tags:
Merck, Dendreon, hepatitis C, Victrelis
Roche and Pfizer launch pharma's first official Google+ pages
PM Live
Tuesday, December 6, 2011 - 11:40am
tags:
Roche, Pfizer, social media, Google+
FDA Extends Taliglucerase Alfa PDUFA Date to May 1, 2012
Yahoo
Tuesday, December 6, 2011 - 11:35am
tags:
FDA, taliglucerase alfa, Protalix BioTherapeutics, Gaucher disease
Genmab says rivals appeal U.S. ruling in patent suit
Reuters
Tuesday, December 6, 2011 - 11:33am
tags:
patents, Genmab, Biogen Idec, Genentech, GSK, Arzerra
False Claims Probe Did Not Stop Off-Label Marketing
Pharmalot
Tuesday, December 6, 2011 - 11:26am
tags:
off-label, False Claims Act, Pfizer, Warner-Lambert, Neurontin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.